proteolysis

For what it's worth, proteolysis does not imply the loss of muscle mass after re-feeding in short-term fasting.

All peptides face similar challenges with absorption; the cyclic peptides simply have less liability to proteolysis.

Perhaps you meant to say that newly synthesised protein uses amino acids of which are most often sourced from proteolysis?

The way insulin is made is somewhat complicated, the best standard is typically production in yeast, followed by reverse proteolysis, then purification and formulation.

As for ketosis sparing muscles that comes from a wide range of effects like low insulin, preserved/increased GH/IGF-1, BHB-inhibited muscle proteolysis and low leucine oxidation.

Stronger proteolysis breaks proteins down into smaller peptides and amino acids and it turns out that those register to our sense of taste as bitterness.

The target protein doesn't have to be inactivated by the therapeutic molecule because the proteolysis machinery destroys it, so requirement #3 from above is effectively removed.

I don't know why anyone would waste their time on some uncharacterized, completely markerless viral vector for these RBD and proteolysis tests.

The molecule in this study does something similar to targeted protein degradation, but this time using a protein that effects gene expression instead of one that recruits proteolysis machinery.

Obviously the fermentation, that breaks down sugars, and the proteolysis, that breaks down proteins, helps the animal digest its milk, but why coagulate it also?

Industrially, insulin is made (in yeast, not E coli) by going ahead and cleaving at that extra site, and then performing a reverse proteolysis to install a synthetically generated peptide, restoring the molecule.

So, to have maximum milk clotting power with slower proteolysis, and less chance of developing bitter tastes, you need to use the rennet from a young animal, preferrably one that hasn't yet eaten grass.

Another response is proteolysis in the muscles, where muscle proteins are broken down ("muscle wasting") in order to feed energy demands.

This idea has been validated extensively in the field of "targeted protein degradation", where a target protein and an E3 ubiquitin ligase, a protein that recruits the cell's native proteolysis machinery, are recruited to each other.

: "Cancer-associated malnutrition is driven by reduced dietary intake and by underlying metabolic changes (such as inflammation, anabolic resistance, proteolysis, lipolysis and futile cycling) induced by the tumour and activated immune cells."